UBS Maintains Sell on Staar Surgical, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 80.7%

Neg 80.7% Neu 0% Pos 0%

UBS analyst Patrick Wood maintains Staar Surgical (NASDAQ:STAA) with a Sell and lowers the price target from $20 to $19.